Purpose

The NANETS Clinical Investigator Scholarship encourages clinicians at the end of their fellowship or beginning of their faculty appointment to pursue a clinical career focused on neuroendocrine tumors. The NCIS emphasizes both the professional development of the scientific clinician (whose time is primarily dedicated to patient care) and the potential of the project to directly impact NET patients.

Award Sponsor

The 2020 NANETS Clinical Investigator Scholarship Award is sponsored by Ipsen Biopharmaceuticals (link is external)

Eligibility

The NANETS Clinical Investigator Scholarship encourages clinicians at the end of their fellowship or beginning of their faculty appointment to pursue a clinical career focused on neuroendocrine tumors. The NCIS emphasizes both the professional development of the scientific clinician (whose time is primarily dedicated to patient care) and the potential of the project to directly impact NET patients.

NANETS welcomes applications from candidates who meet the following criteria:

  • Candidates must have a MD, PhD, MD/PhD, DO degree or equivalent.
  • At the time of funding, candidates must be in the first 6 years of a faculty appointment at an accredited medical school or other institution in North America. Faculty appointments include instructors and above.
  • Candidates must be a NANETS member in good standing.
  • Previous recipients of NBTSI, NCIS or NTIG awards are not eligible to apply.

Selection Criteria

Criteria for selection will include both the clinical project itself and the potential of the individual to make future clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements and the mentor’s development plan. The clinical proposal section should focus on a project with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) correlative studies involving existing clinical trials, retrospective studies, a NET database, risk factors and/or any project with a clear clinical significance.

Award Term

The NANETS Clinical Investigator Scholarship Award is a two-year $100,000 award and will provide $50,000 in funding each year, which will be directed to the sponsoring institution. Notification to the recipient will be made in mid-July 2020. The award period is January 1, 2021 through December 31, 2022. The first installment of funds will be dispersed to the sponsoring institution on or about January 15, 2021.

Reporting Requirements

The recipient must provide NANETS with a written progress report of the project and a budget reconciliation annually. 

Application Review and Notification Process

Applications are reviewed and scored by the NANETS’ Scientific Review & Research Committee comprised of NET medical research experts. Criteria for selection will include both the research proposal itself and the potential of the individual to make future scientific and/or clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements, as well as the research proposal. The research proposals section should focus on research projects with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) studies of neuroendocrine tumor biology, epidemiology, risk factors, clinical outcomes, novel treatment strategies, and translational research projects with clear clinical significance.  

Submission Period

April 1 through June 12, 2020 at 11:59 pm Pacific Standard Time.

Notifications will be made in mid-July.

New Submission Process!

NANETS is using an online system for the submission of applications. The system allows for editing until the June 12th deadline. Instructions are provided once you log in. The online system will lead you through the following required sections:

TITLE AND CATEGORY

  • Project Title
  • Select Category: BTSI, NCIS, NTIG

APPLICANT AND MENTOR(S) INFORMATION

CAREER DEVELOPMENT PLAN

750 word limit. This should be written together by the mentor and applicant. It should include intramural coursework/seminars, involvement in cooperative groups, participation in tumor boards, description of clinical protected time and plans to attend national meetings focused on neuroendocrine tumors.

PERSONAL STATEMENT BY THE CANDIDATE

500 word limit. The applicant should include a description of any past projects, evidence of interest in neuroendocrine tumors, and description of how the project will contribute to the future development of the candidate as a basic science researcher and/or clinician in the field of neuroendocrine tumors.

MENTOR DEVELOPMENT PLAN

500 word limit. The mentor should include a description of how they will enhance the applicant’s career opportunities and leadership skills, outline their role in the mentoring relationship and ability to supervise the applicant, explain how they will provide a positive learning environment to include the institutional commitment of support for the mentor’s time.

PROJECT DESCRIPTION

1,000 word limit. Please refer to the Selection Criteria outlined above and be sure to address the criteria specific to the grant for which you are applying.

PROPOSED BUDGET

Grant funds can be used to support the salary of the applicant, project costs and/or travel. Indirect expenses are capped at five percent (5%). 

UPLOADS (REQUIRED)

  1. NIH Biosketch of Applicant (5 page maximum)
  2. NIH Biosketch of Mentor (5 page maximum)
  3. Letter of Mentor Support (1 page maximum)
  4. Letter of Institutional Support (1 page maximum)
  5. Detailed Budget (xls, xlsx or cvs format)

OPTIONAL: You may upload one file with a maximum of two figures or tables (2 figures, 1 figure and 1 table, or 2 tables). Each figure or table must be numbered and have a clear title.

 

Submit an Application

 

Instructions for Research Grant Submissions

 

Disclaimer

Funding is subject to the approval and availability of grant funds appropriated to NANETS. Therefore, NANETS reserves the right to alter the number of investigator awards, terms and allowances.